首页> 外文期刊>Clinical ophthalmology >Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study
【24h】

Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study

机译:基质内注射两性霉素B和局部氟康唑联合治疗顽固性角化病的回顾性研究

获取原文
           

摘要

Purpose: To evaluate the efficacy of combination therapy of a single intrastromal injection of amphotericin B and topical fluconazole in resistant cases of fungal keratitis, and also topical amphotericin B as monotherapy in terms of the duration of the recovery period and toxic drug effects. Methods: This retrospective 2-year study reviewed 68 cases of unilateral fungal keratitis diagnosed by clinical features and positive laboratory culture results. Forty-one cases were resistant and did not respond to monotherapy with an antifungal agent. Thus, they were treated with a single intrastromal injection of amphotericin B in addition to topical fluconazole as combined antifungal therapy, representing group A. Twenty-seven cases were treated with topical amphotericin B as antifungal monotherapy, representing group B. Topical atropine 1% and different antibiotic eye drops were added to the antifungal agents in both groups. Follow-up of patient records was performed monitoring cure rate, duration of recovery period, and toxic drug effects such as pain, burning sensation, and corneal melting. Results: The results revealed that group A, treated with combination therapy, showed recovery of 34 cases (82.9%) with a mean duration of 24±6.42 days, significantly different from group?B which showed recovery of 16 cases (59.3%) with a mean duration of 39.66±13.6 days. Group?A also showed less manifestation of drug toxicity than group B. Conclusion: Combined intrastromal injection of amphotericin B and topical fluconazole can provide a good modality in the treatment of resistant cases of fungal keratitis, exhibiting highly potent antifungal effects, shorter recovery period, and reduced corneal toxicity.
机译:目的:就恢复期的持续时间和毒性药物作用,评估一次单次基质内注射两性霉素B和局部氟康唑联合治疗在耐药性真菌性角膜炎病例中的作用,以及局部使用两性霉素B作为单一治疗的疗效。方法:这项为期2年的回顾性研究回顾了68例经临床特征和实验室培养阳性结果诊断为单侧真菌性角膜炎的病例。 41例有抗药性,对抗真菌药的单药治疗无反应。因此,除局部使用氟康唑外,还接受了单次基质内注射两性霉素B的联合抗真菌治疗,代表A组。对二十七例患者进行了局部两性霉素B的抗真菌单药治疗,代表了B组。局部使用阿托品1%两组均在抗真菌药中添加了不同的抗生素眼药水。对患者记录进行随访,以监测治愈率,恢复期的持续时间以及有毒药物的作用,例如疼痛,烧灼感和角膜融化。结果:结果显示,经联合疗法治疗的A组恢复34例(82.9%),平均持续时间为24±6.42天,与?B组显着不同,B组恢复16例(59.3%)。平均持续时间为39.66±13.6天。 A组的药物毒性表现也少于B组。结论:基质内注射两性霉素B和局部氟康唑可以在耐药性真菌性角膜炎病例中提供良好的治疗方法,具有很强的抗真菌作用,恢复期短,并降低了角膜毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号